News
![Globe newswire](https://labcentralorg.blob.core.windows.net/labcentralorg/images/Article-images/_eventBanner/114492/globe-newswire.webp?v=1714884906)
Acrivon Therapeutics Closes Oversubscribed $100 Million Series B Financing to Advance its Innovative Precision Proteomics Platform and Clinical Oncology Pipeline
Acrivon Therapeutics Closes Oversubscribed $100 Million Series B Financing to Advance its Innovative Precision Proteomics Platform and Clinical Oncology Pipeline